Global Anti-tuberculosis Therapeutics Market Size, Status and Forecast 2024-2031

Report ID: 920888 | Published Date: Nov 2024 | No. of Page: 106 | Base Year: 2023 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Anti-tuberculosis Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Isoniazid
        1.2.3 Rifampin
        1.2.4 Ethambutol
        1.2.5 Pyrazinamide
        1.2.6 Otherr
    1.3 Market by Application
        1.3.1 Global Anti-tuberculosis Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals and Clinics
        1.3.3 Government Agencies
        1.3.4 Non-Profit Organizations
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Anti-tuberculosis Therapeutics Market Perspective (2016-2027)
    2.2 Anti-tuberculosis Therapeutics Growth Trends by Regions
        2.2.1 Anti-tuberculosis Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Anti-tuberculosis Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 Anti-tuberculosis Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 Anti-tuberculosis Therapeutics Industry Dynamic
        2.3.1 Anti-tuberculosis Therapeutics Market Trends
        2.3.2 Anti-tuberculosis Therapeutics Market Drivers
        2.3.3 Anti-tuberculosis Therapeutics Market Challenges
        2.3.4 Anti-tuberculosis Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Anti-tuberculosis Therapeutics Players by Revenue
        3.1.1 Global Top Anti-tuberculosis Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global Anti-tuberculosis Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global Anti-tuberculosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Anti-tuberculosis Therapeutics Revenue
    3.4 Global Anti-tuberculosis Therapeutics Market Concentration Ratio
        3.4.1 Global Anti-tuberculosis Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Anti-tuberculosis Therapeutics Revenue in 2020
    3.5 Anti-tuberculosis Therapeutics Key Players Head office and Area Served
    3.6 Key Players Anti-tuberculosis Therapeutics Product Solution and Service
    3.7 Date of Enter into Anti-tuberculosis Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-tuberculosis Therapeutics Breakdown Data by Type
    4.1 Global Anti-tuberculosis Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global Anti-tuberculosis Therapeutics Forecasted Market Size by Type (2022-2027)

5 Anti-tuberculosis Therapeutics Breakdown Data by Application
    5.1 Global Anti-tuberculosis Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global Anti-tuberculosis Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Anti-tuberculosis Therapeutics Market Size (2016-2027)
    6.2 North America Anti-tuberculosis Therapeutics Market Size by Type
        6.2.1 North America Anti-tuberculosis Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America Anti-tuberculosis Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America Anti-tuberculosis Therapeutics Market Size by Type (2016-2027)
    6.3 North America Anti-tuberculosis Therapeutics Market Size by Application
        6.3.1 North America Anti-tuberculosis Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America Anti-tuberculosis Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America Anti-tuberculosis Therapeutics Market Size by Application (2016-2027)
    6.4 North America Anti-tuberculosis Therapeutics Market Size by Country
        6.4.1 North America Anti-tuberculosis Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America Anti-tuberculosis Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Anti-tuberculosis Therapeutics Market Size (2016-2027)
    7.2 Europe Anti-tuberculosis Therapeutics Market Size by Type
        7.2.1 Europe Anti-tuberculosis Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe Anti-tuberculosis Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe Anti-tuberculosis Therapeutics Market Size by Type (2016-2027)
    7.3 Europe Anti-tuberculosis Therapeutics Market Size by Application
        7.3.1 Europe Anti-tuberculosis Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe Anti-tuberculosis Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe Anti-tuberculosis Therapeutics Market Size by Application (2016-2027)
    7.4 Europe Anti-tuberculosis Therapeutics Market Size by Country
        7.4.1 Europe Anti-tuberculosis Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe Anti-tuberculosis Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Anti-tuberculosis Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Anti-tuberculosis Therapeutics Market Size (2016-2027)
    9.2 Latin America Anti-tuberculosis Therapeutics Market Size by Type
        9.2.1 Latin America Anti-tuberculosis Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America Anti-tuberculosis Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America Anti-tuberculosis Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America Anti-tuberculosis Therapeutics Market Size by Application
        9.3.1 Latin America Anti-tuberculosis Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America Anti-tuberculosis Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America Anti-tuberculosis Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America Anti-tuberculosis Therapeutics Market Size by Country
        9.4.1 Latin America Anti-tuberculosis Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America Anti-tuberculosis Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Anti-tuberculosis Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Lupin
        11.1.1 Lupin Company Details
        11.1.2 Lupin Business Overview
        11.1.3 Lupin Anti-tuberculosis Therapeutics Introduction
        11.1.4 Lupin Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
        11.1.5 Lupin Recent Development
    11.2 Macleods Pharmaceuticals
        11.2.1 Macleods Pharmaceuticals Company Details
        11.2.2 Macleods Pharmaceuticals Business Overview
        11.2.3 Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Introduction
        11.2.4 Macleods Pharmaceuticals Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
        11.2.5 Macleods Pharmaceuticals Recent Development
    11.3 Otsuka Pharmaceutical
        11.3.1 Otsuka Pharmaceutical Company Details
        11.3.2 Otsuka Pharmaceutical Business Overview
        11.3.3 Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Introduction
        11.3.4 Otsuka Pharmaceutical Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
        11.3.5 Otsuka Pharmaceutical Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Details
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Anti-tuberculosis Therapeutics Introduction
        11.4.4 Johnson & Johnson Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
        11.4.5 Johnson & Johnson Recent Development
    11.5 Pfizer
        11.5.1 Pfizer Company Details
        11.5.2 Pfizer Business Overview
        11.5.3 Pfizer Anti-tuberculosis Therapeutics Introduction
        11.5.4 Pfizer Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
        11.5.5 Pfizer Recent Development
    11.6 Novartis
        11.6.1 Novartis Company Details
        11.6.2 Novartis Business Overview
        11.6.3 Novartis Anti-tuberculosis Therapeutics Introduction
        11.6.4 Novartis Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
        11.6.5 Novartis Recent Development
    11.7 Abbott
        11.7.1 Abbott Company Details
        11.7.2 Abbott Business Overview
        11.7.3 Abbott Anti-tuberculosis Therapeutics Introduction
        11.7.4 Abbott Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
        11.7.5 Abbott Recent Development
    11.8 AstraZeneca
        11.8.1 AstraZeneca Company Details
        11.8.2 AstraZeneca Business Overview
        11.8.3 AstraZeneca Anti-tuberculosis Therapeutics Introduction
        11.8.4 AstraZeneca Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
        11.8.5 AstraZeneca Recent Development
    11.9 Bayer
        11.9.1 Bayer Company Details
        11.9.2 Bayer Business Overview
        11.9.3 Bayer Anti-tuberculosis Therapeutics Introduction
        11.9.4 Bayer Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
        11.9.5 Bayer Recent Development
    11.10 Eli Lilly
        11.10.1 Eli Lilly Company Details
        11.10.2 Eli Lilly Business Overview
        11.10.3 Eli Lilly Anti-tuberculosis Therapeutics Introduction
        11.10.4 Eli Lilly Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
        11.10.5 Eli Lilly Recent Development
    11.11 GlaxoSmithKline
        11.11.1 GlaxoSmithKline Company Details
        11.11.2 GlaxoSmithKline Business Overview
        11.11.3 GlaxoSmithKline Anti-tuberculosis Therapeutics Introduction
        11.11.4 GlaxoSmithKline Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
        11.11.5 GlaxoSmithKline Recent Development
    11.12 Merck
        11.12.1 Merck Company Details
        11.12.2 Merck Business Overview
        11.12.3 Merck Anti-tuberculosis Therapeutics Introduction
        11.12.4 Merck Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
        11.12.5 Merck Recent Development
    11.13 Sanofi
        11.13.1 Sanofi Company Details
        11.13.2 Sanofi Business Overview
        11.13.3 Sanofi Anti-tuberculosis Therapeutics Introduction
        11.13.4 Sanofi Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
        11.13.5 Sanofi Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Anti-tuberculosis Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Isoniazid
    Table 3. Key Players of Rifampin
    Table 4. Key Players of Ethambutol
    Table 5. Key Players of Pyrazinamide
    Table 6. Key Players of Otherr
    Table 7. Global Anti-tuberculosis Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Anti-tuberculosis Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Anti-tuberculosis Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Anti-tuberculosis Therapeutics Market Share by Regions (2016-2021)
    Table 11. Global Anti-tuberculosis Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Anti-tuberculosis Therapeutics Market Share by Regions (2022-2027)
    Table 13. Anti-tuberculosis Therapeutics Market Trends
    Table 14. Anti-tuberculosis Therapeutics Market Drivers
    Table 15. Anti-tuberculosis Therapeutics Market Challenges
    Table 16. Anti-tuberculosis Therapeutics Market Restraints
    Table 17. Global Anti-tuberculosis Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Anti-tuberculosis Therapeutics Market Share by Players (2016-2021)
    Table 19. Global Top Anti-tuberculosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-tuberculosis Therapeutics as of 2020)
    Table 20. Ranking of Global Top Anti-tuberculosis Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Anti-tuberculosis Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Anti-tuberculosis Therapeutics Product Solution and Service
    Table 24. Date of Enter into Anti-tuberculosis Therapeutics Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Anti-tuberculosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Anti-tuberculosis Therapeutics Revenue Market Share by Type (2016-2021)
    Table 28. Global Anti-tuberculosis Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Anti-tuberculosis Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Anti-tuberculosis Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Anti-tuberculosis Therapeutics Revenue Market Share by Application (2016-2021)
    Table 32. Global Anti-tuberculosis Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Anti-tuberculosis Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Anti-tuberculosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Anti-tuberculosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Anti-tuberculosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Anti-tuberculosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Anti-tuberculosis Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America Anti-tuberculosis Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe Anti-tuberculosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Anti-tuberculosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Anti-tuberculosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Anti-tuberculosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Anti-tuberculosis Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe Anti-tuberculosis Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America Anti-tuberculosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Anti-tuberculosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Anti-tuberculosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Anti-tuberculosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Anti-tuberculosis Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America Anti-tuberculosis Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Lupin Company Details
    Table 65. Lupin Business Overview
    Table 66. Lupin Anti-tuberculosis Therapeutics Product
    Table 67. Lupin Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
    Table 68. Lupin Recent Development
    Table 69. Macleods Pharmaceuticals Company Details
    Table 70. Macleods Pharmaceuticals Business Overview
    Table 71. Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Product
    Table 72. Macleods Pharmaceuticals Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
    Table 73. Macleods Pharmaceuticals Recent Development
    Table 74. Otsuka Pharmaceutical Company Details
    Table 75. Otsuka Pharmaceutical Business Overview
    Table 76. Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Product
    Table 77. Otsuka Pharmaceutical Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
    Table 78. Otsuka Pharmaceutical Recent Development
    Table 79. Johnson & Johnson Company Details
    Table 80. Johnson & Johnson Business Overview
    Table 81. Johnson & Johnson Anti-tuberculosis Therapeutics Product
    Table 82. Johnson & Johnson Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
    Table 83. Johnson & Johnson Recent Development
    Table 84. Pfizer Company Details
    Table 85. Pfizer Business Overview
    Table 86. Pfizer Anti-tuberculosis Therapeutics Product
    Table 87. Pfizer Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
    Table 88. Pfizer Recent Development
    Table 89. Novartis Company Details
    Table 90. Novartis Business Overview
    Table 91. Novartis Anti-tuberculosis Therapeutics Product
    Table 92. Novartis Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
    Table 93. Novartis Recent Development
    Table 94. Abbott Company Details
    Table 95. Abbott Business Overview
    Table 96. Abbott Anti-tuberculosis Therapeutics Product
    Table 97. Abbott Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
    Table 98. Abbott Recent Development
    Table 99. AstraZeneca Company Details
    Table 100. AstraZeneca Business Overview
    Table 101. AstraZeneca Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
    Table 102. AstraZeneca Recent Development
    Table 103. Bayer Company Details
    Table 104. Bayer Business Overview
    Table 105. Bayer Anti-tuberculosis Therapeutics Product
    Table 106. Bayer Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
    Table 107. Bayer Recent Development
    Table 108. Eli Lilly Company Details
    Table 109. Eli Lilly Business Overview
    Table 110. Eli Lilly Anti-tuberculosis Therapeutics Product
    Table 111. Eli Lilly Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
    Table 112. Eli Lilly Recent Development
    Table 113. GlaxoSmithKline Company Details
    Table 114. GlaxoSmithKline Business Overview
    Table 115. GlaxoSmithKline Anti-tuberculosis Therapeutics Product
    Table 116. GlaxoSmithKline Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
    Table 117. GlaxoSmithKline Recent Development
    Table 118. Merck Company Details
    Table 119. Merck Business Overview
    Table 120. Merck Anti-tuberculosis Therapeutics Product
    Table 121. Merck Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
    Table 122. Merck Recent Development
    Table 123. Sanofi Company Details
    Table 124. Sanofi Business Overview
    Table 125. Sanofi Anti-tuberculosis Therapeutics Product
    Table 126. Sanofi Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
    Table 127. Sanofi Recent Development
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Anti-tuberculosis Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. Isoniazid Features
    Figure 3. Rifampin Features
    Figure 4. Ethambutol Features
    Figure 5. Pyrazinamide Features
    Figure 6. Otherr Features
    Figure 7. Global Anti-tuberculosis Therapeutics Market Share by Application: 2020 VS 2027
    Figure 8. Hospitals and Clinics Case Studies
    Figure 9. Government Agencies Case Studies
    Figure 10. Non-Profit Organizations Case Studies
    Figure 11. Others Case Studies
    Figure 12. Anti-tuberculosis Therapeutics Report Years Considered
    Figure 13. Global Anti-tuberculosis Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 14. Global Anti-tuberculosis Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global Anti-tuberculosis Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 16. Global Anti-tuberculosis Therapeutics Market Share by Regions (2022-2027)
    Figure 17. Global Anti-tuberculosis Therapeutics Market Share by Players in 2020
    Figure 18. Global Top Anti-tuberculosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-tuberculosis Therapeutics as of 2020
    Figure 19. The Top 10 and 5 Players Market Share by Anti-tuberculosis Therapeutics Revenue in 2020
    Figure 20. Global Anti-tuberculosis Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 21. Global Anti-tuberculosis Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 22. North America Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. North America Anti-tuberculosis Therapeutics Market Share by Type (2016-2027)
    Figure 24. North America Anti-tuberculosis Therapeutics Market Share by Application (2016-2027)
    Figure 25. North America Anti-tuberculosis Therapeutics Market Share by Country (2016-2027)
    Figure 26. United States Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Canada Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Anti-tuberculosis Therapeutics Market Share by Type (2016-2027)
    Figure 30. Europe Anti-tuberculosis Therapeutics Market Share by Application (2016-2027)
    Figure 31. Europe Anti-tuberculosis Therapeutics Market Share by Country (2016-2027)
    Figure 32. Germany Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. France Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. U.K. Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Italy Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Russia Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Nordic Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Anti-tuberculosis Therapeutics Market Share by Type (2016-2027)
    Figure 40. Asia-Pacific Anti-tuberculosis Therapeutics Market Share by Application (2016-2027)
    Figure 41. Asia-Pacific Anti-tuberculosis Therapeutics Market Share by Region (2016-2027)
    Figure 42. China Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Japan Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. South Korea Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Southeast Asia Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. India Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Australia Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Anti-tuberculosis Therapeutics Market Share by Type (2016-2027)
    Figure 50. Latin America Anti-tuberculosis Therapeutics Market Share by Application (2016-2027)
    Figure 51. Latin America Anti-tuberculosis Therapeutics Market Share by Country (2016-2027)
    Figure 52. Mexico Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Brazil Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Anti-tuberculosis Therapeutics Market Share by Type (2016-2027)
    Figure 56. Middle East & Africa Anti-tuberculosis Therapeutics Market Share by Application (2016-2027)
    Figure 57. Middle East & Africa Anti-tuberculosis Therapeutics Market Share by Country (2016-2027)
    Figure 58. Turkey Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Saudi Arabia Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. UAE Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Lupin Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
    Figure 62. Macleods Pharmaceuticals Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
    Figure 63. Otsuka Pharmaceutical Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
    Figure 64. Johnson & Johnson Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
    Figure 65. Pfizer Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
    Figure 66. Novartis Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
    Figure 67. Abbott Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
    Figure 68. AstraZeneca Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
    Figure 69. Bayer Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
    Figure 70. Eli Lilly Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
    Figure 71. GlaxoSmithKline Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
    Figure 72. Merck Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
    Figure 73. Sanofi Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Lupin
Macleods Pharmaceuticals
Otsuka Pharmaceutical
Johnson & Johnson
Pfizer
Novartis
Abbott
AstraZeneca
Bayer
Eli Lilly
GlaxoSmithKline
Merck
Sanofi
Frequently Asked Questions
Anti-tuberculosis Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Anti-tuberculosis Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Anti-tuberculosis Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports